Aims and Scope

The GMB Case Reports aims to provide an international platform for the publication of high-quality, peer-reviewed case reports that contribute to the advancement of medical knowledge and healthcare practices. The journal is dedicated to documenting rare, complex, and novel medical and biomedical cases, as well as innovations in diagnosis, management, and treatment across a wide array of clinical and scientific disciplines.

Aims

1. Dissemination of Knowledge: We aim to share unique, uncommon, or educationally significant medical cases with the global healthcare and biomedical research communities.
2. Clinical Insight and Learning: Our goal is to present case reports that provide practical insights into diagnosis, therapeutic strategies, and patient management, offering valuable lessons for both clinicians and researchers.
3. Promotion of Innovation: We encourage the publication of case reports that highlight novel treatment methods, surgical techniques, medical devices, or approaches to disease management that can inspire further research and clinical practice improvements.
4. Encouragement of Collaboration: GMB Case Reports fosters interdisciplinary and international collaboration by bringing together contributions from clinicians, researchers, and healthcare professionals across various specialties and countries.

Scope

The journal covers a comprehensive range of specialties within the medical and biomedical fields, inviting contributions from both clinical and research settings. Our scope includes but is not limited to:

• Internal Medicine: Case reports on the diagnosis and management of diseases affecting internal organs, including gastrointestinal, renal, pulmonary, endocrine, and autoimmune disorders.
• Surgical Cases: Innovative techniques and unique surgical cases from general surgery, neurosurgery, cardiovascular surgery, and other subspecialties.
• Pediatrics: Clinical insights into rare pediatric diseases, congenital abnormalities, and child-specific treatment approaches.
• Oncology: Case studies on rare cancers, experimental therapies, and breakthroughs in cancer treatment and diagnosis.
• Neurology: Uncommon neurological conditions, neurodegenerative disorders, and advances in neurodiagnostics and neurosurgery.
• Cardiology: Case reports covering rare cardiac diseases, innovative interventions, and updates in cardiac care.
• Infectious Diseases: Emerging infections, rare pathogens, and case reports involving novel approaches to infection control and treatment.
• Radiology and Imaging: Advanced imaging techniques, unique diagnostic findings, and their implications for patient management.
• Orthopedics: Rare orthopedic conditions, challenging surgical cases, and new treatment methodologies.
• Public Health and Epidemiology: Cases involving public health emergencies, epidemiological insights, and the management of population health concerns.
• Biomedical Research: Breakthroughs in biotechnology, molecular medicine, genetics, genomics, and translational research with clinical applications.

Types of Case Reports Published

• Unique Clinical Presentations: Reports that document rare or unusual clinical conditions.
• Novel Diagnostic Methods: Case studies highlighting innovative diagnostic techniques, tools, or protocols.
• Therapeutic Challenges: Cases where treatment was complex, multidisciplinary, or required novel approaches.
• Unexpected Outcomes: Reports of cases with unexpected treatment outcomes or complications, offering valuable insights into clinical practice.
• Interdisciplinary Cases: Cases involving collaboration between multiple specialties or fields of biomedical science.

We welcome submissions from clinicians, researchers, and medical professionals worldwide and encourage interdisciplinary case reports that promote knowledge exchange and clinical improvement.

Through the publication of these case reports, GMB Case Reports seeks to enhance the collective understanding of medical and biomedical science, foster ongoing learning, and contribute to improved patient outcomes globally.